Potential value of efficacy prediction and treatment of natural killer cells in extensive stage small cell lung cancer
Abstract Although the emergence of immunotherapy has broken the deadlock of extensive stage small cell lung cancer (ES‐SCLC), the study of markers for predicting efficacy is the key to the breakthrough of immunotherapy, and exploring more innovative, efficient and safe treatment models is also an im...
| 出版年: | Thoracic Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2023-04-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1111/1759-7714.14837 |